Jefferies London: Sofinnova Partners announced a new $750M fund XI today that will invest in early stage companies in biotech
Chairman and managing partner Antoine Papiernik tells us about the fund and how he expects to deploy it. Plus, the current state of European biotech.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.